Showing results (11-20 of 318) with videos related to
Sort By:
Pageof 32
Biomed Research International|July 4, 2014
MicroRNA: important player in the pathobiology of multiple myelomaChonglei Bi, Wee Joo ChngBlood Cancer Journal|April 30, 2021
CAR T-cell therapy in multiple myeloma: more room for improvementPhaik Ju Teoh, Wee Joo ChngF1000Research|August 11, 2017
Recent advances in acute promyelocytic leukaemiaChin-Hin Ng, Wee-Joo ChngEuropean Journal of Haematology|July 26, 2022
Treatment horizon in multiple myelomaCinnie Yentia Soekojo, Wee Joo ChngChinese Medical Journal|November 2, 2011
miRNA deregulation in multiple myelomaChong Lei Bi, Wee Joo ChngEuropean Journal of Haematology|July 26, 2022
The evolution of immune dysfunction in multiple myelomaCinnie Yentia Soekojo, Wee Joo ChngThe International Journal of Biochemistry & Cell Biology|October 4, 2011
TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanismsJianbiao Zhou, Qiang Yu, Wee-Joo ChngCellular and Molecular Life Sciences : CMLS|August 2, 2018
ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemiaJianbiao Zhou, Yvonne Ng, Wee-Joo ChngBlood|July 3, 2025
Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tailsSinan Xiong, Jianbiao Zhou, Wee Joo ChngCellular and Molecular Life Sciences : CMLS|February 18, 2021
Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaSinan Xiong, Wee-Joo Chng, Jianbiao ZhouPageof 32